Is toll-like receptor-2 really inhibiting FoxP3+ TLR2+ cells and enhancing the anti-tumour response in oral squamous cell carcinoma?

@article{Zeng2017IsTR,
  title={Is toll-like receptor-2 really inhibiting FoxP3+ TLR2+ cells and enhancing the anti-tumour response in oral squamous cell carcinoma?},
  author={Xi Rui Zeng and Mengting Li and Guang-dong Liao and Ming-rong Xi},
  journal={Acta histochemica},
  year={2017},
  volume={119 7},
  pages={
          766-767
        }
}
We are responding to the article by H.M. Hussaini et al. on “Forkhead box-P3+ regulatory T cells (Treg) and toll-like receptor-2 (TLR-2) coexpression in oral squamous cell carcinoma”(Volume 119, Issue 3, pp 205–210), which addressed a research for the association between Treg and TLR-2. In the article, after immunohistochemistry and immunofluorescence stains, they suggested a hypothesis that “the presence of FoxP3+ TLR2+ cells within the OSCC microenvironment may represent a dendritic cell… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-8 OF 8 REFERENCES

immunological pathways in uterine cervical neoplasms

A. Ghosh, A. Dasgupta, +5 authors A. Basu
  • 2015
VIEW 2 EXCERPTS

Significant association between toll-like receptor gene polymorphisms and gallbladder cancer.

  • Liver international : official journal of the International Association for the Study of the Liver
  • 2010
VIEW 2 EXCERPTS

Assessment of expression of toll-like receptors 2, 3 and 4 in laryngeal carcinoma

Mirosław Szczepański, Maria Stelmachowska, +4 authors Jan Żeromski
  • European Archives of Oto-Rhino-Laryngology
  • 2006